Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.2700 (-1.69%) ($18.2700 - $18.2700) on Wed. Feb. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.19% (three month average) | RSI | 48 | Latest Price | $18.2700(-1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.595% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-15%) UNG(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.595% (StdDev 3.19%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $19.12 | 5 Day Moving Average | $18.77(-2.66%) | 10 Day Moving Average | $19.33(-5.48%) | 20 Day Moving Average | $19.12(-4.45%) | To recent high | -30.6% | To recent low | 0.2% | Market Cap | $1.358b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |